A brief report on rapid access to medication assisted treatment

References

• Belar, C. (2014) Introducing transdisciplinary professionalism. In Global Forum on Innovation in Health Professional Education; Board on Global Health; Institute of Medicine. Establishing Transdisciplinary Professionalism for Improving Health Outcomes: Workshop Summary. Washington, DC: National Academies Press (US).
   Google Scholar
• Bolland, J. M., & Wilson, J. V. (1994). Three faces of integrative coordination: A model of interorganizational relations in community-based health and human services. Health Services Research, 29(3), 341–366.
   PubMed Web of Science ®Google Scholar
• Brekke, J. S. (2014). A science of social work, and social work as an integrative scientific discipline: Have we gone too far, or not far enough? Research on Social Work Practice, 24(5), 517–523. doi:https://doi.org/10.1177/1049731513511994
   Web of Science ®Google Scholar
• Brooklyn, J. R., & Sigmon, S. C. (2017). Vermont hub-and-spoke model of care for opioid use disorder: Development, implementation, and impact. Journal of Addiction Medicine, 11(4), 286–292. doi:https://doi.org/10.1097/ADM.0000000000000310
   PubMed Web of Science ®Google Scholar
• Bunger, A. C. (2010). Defining service coordination: A social work Perspective. Journal of Social Service Research, 36(5), 385–401. doi:https://doi.org/10.1080/01488376.2010.510931
   PubMed Web of Science ®Google Scholar
• Busch, S. H., Fiellin, D. A., Chawarski, M. C., Owens, P. H., Pantalon, M. V., Hawk, K., … D’Onofrio, G. (2017). Cost‐effectiveness of emergency department‐initiated treatment for opioid dependence. Addiction, 112(11), 2002–2010. doi:https://doi.org/10.1111/add.13900
   PubMed Web of Science ®Google Scholar
• D’Onofrio, G., O’Connor, P. G., Pantalon, M. V., Chawarski, M. C., Busch, S. H., Owens, P. H., … Fiellin, D. A. (2015). Emergency department initiated buprenorphine/naloxone treatment for opioid dependence: A randomized clinical trial. JAMA, 313(16), 1636. doi:https://doi.org/10.1001/jama.2015.3474
   PubMed Web of Science ®Google Scholar
• Darfler, K., Sandoval, J., Pearce Antonini, V., & Urada, D. (2019). Preliminary results of the evaluation of the california hub and spoke program. Journal of Substance Abuse Treatment. No Pagination Specified-No Pagination Specified. doi:https://doi.org/10.1016/j.jsat.2019.07.014
   Google Scholar
• Hedegaard, H. (2020). Drug Overdose Deaths in the United States, 1999–2018. 356, 8.
   Google Scholar
• Jakubowski, A., & Fox, A. (2020). Defining low-threshold buprenorphine treatment. Journal of Addiction Medicine, 14(2), 95–98. doi:https://doi.org/10.1097/ADM.0000000000000555
   PubMed Web of Science ®Google Scholar
• LaBelle, C. T., Han, S. C., Bergeron, A., & Samet, J. H. (2016). Office-based opioid treatment with buprenorphine (OBOT-B): Statewide implementation of the massachusetts collaborative care model in community health centers. Journal of Substance Abuse Treatment, 60, 6–13. doi:https://doi.org/10.1016/j.jsat.2015.06.010
   PubMed Web of Science ®Google Scholar
• Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., … Walley, A. Y. (2018). Medication for opioid use disorder after nonfatal opioid overdose and association with mortality. Annals of Internal Medicine, 169(3), 137–145. doi:https://doi.org/10.7326/M17-3107
   PubMed Web of Science ®Google Scholar
• Miele, G. M., Caton, L., Freese, T. E., McGovern, M., Darfler, K., Antonini, V. P., … Rawson, R. (2019). Implementation of the hub and spoke model for opioid use disorders in california: Rationale, design and anticipated impact. Journal of Substance Abuse Treatment. No Pagination Specified-No Pagination Specified. doi:https://doi.org/10.1016/j.jsat.2019.07.013
   Google Scholar
• NIDA. (2020, May 2). Vermont: Opioid-involved deaths and related harms. Retrieved from https://www.drugabuse.gov/drug-topics/opioids/opioid-summaries-by-state/vermont-opioid-involved-deaths-related-harms
   Google Scholar
• Nielsen, S., Larance, B., Degenhardt, L., Gowing, L., Kehler, C., & Lintzeris, N. (2016). Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database of Systematic Reviews. doi:https://doi.org/10.1002/14651858.CD011117.pub2
   Google Scholar
• O’Brien, P., Schrader, K., Waddel, A., & Mulvaney-Day, N. (2020). Models for medication assisted treatment for opioid use disorder, retention, and continuity of care. Report Prepared for Office of Disability, Aging and Long-Term Care Policy, Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services. IBM Watson Health.
   Google Scholar
• Payne, B. E., Klein, J. W., Simon, C. B., James, J. R., Jackson, S. L., Merrill, J. O., … Tsui, J. I. (2019). Effect of lowering initiation thresholds in a primary care-based buprenorphine treatment program. Drug and Alcohol Dependence, 200, 71–77. doi:https://doi.org/10.1016/j.drugalcdep.2019.03.009
   PubMed Web of Science ®Google Scholar
• Reif, S., Brolin, M. F., Stewart, M. T., Fuchs, T. J., Speaker, E., & Mazel, S. B. (2019). The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders. Journal of Substance Abuse Treatment, 108, 33–39. edselp. Retrieved from http://proxy.library.nyu.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=edselp&AN=S0740547219300637&site=eds-live
   PubMed Web of Science ®Google Scholar
• Rosenblatt, R. A., Andrilla, C. H. A., Catlin, M., & Larson, E. H. (2015). Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Annals of Family Medicine, 13(1), 23–26. doi:https://doi.org/10.1370/afm.1735
   PubMed Web of Science ®Google Scholar
• Rosenblum, A., Cleland, C. M., Fong, C., Kayman, D. J., Tempalski, B., & Parrino, M. (2011). Distance traveled and cross-state commuting to opioid treatment programs in the United States. Journal of Environmental and Public Health, 2011, 1–10. doi:https://doi.org/10.1155/2011/948789
   Google Scholar
• Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016). Increases in drug and opioid overdose deaths—United States, 2000–2014. Morbidity and Mortality Weekly Report, 64(50 & 51) JSTOR, 1378–1382. doi:https://doi.org/10.2307/24856945
   PubMed Web of Science ®Google Scholar
• Shapiro, C. (2019, April 1). Why did opioid overdose deaths drop 50% in Chittenden County? UVM Health News. Retrieved from https://news.uvmhealth.org/opioids/news/opioid-overdose-deaths/
   Google Scholar
• Sigmon, S. C. (2014). Access to treatment for opioid dependence in rural America: Challenges and future directions. JAMA Psychiatry, 71(4), 359–360. doi:https://doi.org/10.1001/jamapsychiatry.2013.4450
   PubMed Web of Science ®Google Scholar
• Simpatico, T. A. (2015). Vermont responds to its opioid crisis. Preventive Medicine: An International Journal Devoted to Practice and Theory, 80, 10–11. doi:https://doi.org/10.1016/j.ypmed.2015.04.002
   PubMed Web of Science ®Google Scholar
• Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., … Pastor-Barriuso, R. (2017). Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. BMJ (Clinical Research Ed.), 357, j1550. doi:https://doi.org/10.1136/bmj.j1550
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS). (2018). Data on substance abuse treatment facilities. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2019.
   Google Scholar